Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Objective: The cleavage and polyadenylation endonuclease CPSF73 is thought to be the target of the anti-trypanosomal benzoxaboroles AN7973, acoziborole and AN11736. We previously showed that AN7973 inhibits mRNA processing. We here investigated whether the drug candidates acoziborole (for human sleeping sickness) and AN11736 (for nagana in cattle) have the same effect. We also affinity purified tagged CPSF73 from parasites without, or after, AN7973 treatment, and analysed differentially co-purified proteins by mass spectrometry. Results: AN11736 and acoziborole both inhibited mRNA processing, as demonstrated by decreased levels of spliced mRNAs and accumulation of di- and tri-cistronic mRNAs from the alpha-beta tubulin locus. Treating the cells with AN7973 for 30 min. did not significantly affect the proteins that copurified with CPSF73.

Cite

CITATION STYLE

APA

Waithaka, A., & Clayton, C. (2022). Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei. BMC Research Notes, 15(1). https://doi.org/10.1186/s13104-022-06258-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free